Cargando…
Biomarkers in the development of individualized treatment regimens for colorectal cancer
INTRODUCTION: Colorectal cancer (CRC) is the third most common and second most deadly malignancy in the world with an estimated 1. 9 million cases and 0.9 million deaths in 2020. The 5-year overall survival for stage I disease is 92% compared to a dismal 11% in stage IV disease. At initial presentat...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749006/ https://www.ncbi.nlm.nih.gov/pubmed/36530921 http://dx.doi.org/10.3389/fmed.2022.1062423 |